XML 36 R27.htm IDEA: XBRL DOCUMENT
v3.25.2

Description of Business and Significant Accounting Policies (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Accounting Policies [Abstract] |
Schedule of Segment Revenues and Significant Expense Categories in Consolidated Statements of Operations | The table below shows the details of the Company’s segment revenues and significant expense categories regularly provided to and reviewed by the CODM as well as other significant segment items included in consolidated net income in the condensed consolidated statements of operations:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
Revenues |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Afrezza |  | $ | 18,329 |  |  | $ | 16,289 |  |  | $ | 33,216 |  |  | $ | 30,727 |
V-Go |  |  | 4,125 |  |  |  | 4,491 |  |  |  | 8,211 |  |  |  | 8,817 |
Collaborations and services |  |  | 22,845 |  |  |  | 26,014 |  |  |  | 52,221 |  |  |  | 50,862 |
Royalties |  |  | 31,228 |  |  |  | 25,592 |  |  |  | 61,233 |  |  |  | 48,243 |
Total revenues |  |  | 76,527 |  |  |  | 72,386 |  |  |  | 154,881 |  |  |  | 138,649 |
Less significant segment expenses (income): |  |  |  |  |  |  |  |  |  |  |  |
Cost of goods sold – commercial |  |  | 4,607 |  |  |  | 5,605 |  |  |  | 8,375 |  |  |  | 9,424 |
Cost of revenue – collaborations and services |  |  | 15,961 |  |  |  | 14,772 |  |  |  | 29,709 |  |  |  | 29,551 |
Research and development |  |  | 13,675 |  |  |  | 11,816 |  |  |  | 24,697 |  |  |  | 21,829 |
Selling |  |  | 14,878 |  |  |  | 11,495 |  |  |  | 28,641 |  |  |  | 23,096 |
General and administrative |  |  | 16,744 |  |  |  | 12,617 |  |  |  | 27,995 |  |  |  | 23,345 |
Interest income, net |  |  | (1,832 | ) |  |  | (3,177 | ) |  |  | (3,788 | ) |  |  | (6,611 | )
Interest expense, net |  |  | 6,191 |  |  |  | 12,878 |  |  |  | 16,823 |  |  |  | 22,140 |
Loss on settlement of debt |  |  | — |  |  |  | 7,050 |  |  |  | — |  |  |  | 7,050 |
Other segment items(1) |  |  | 5,635 |  |  |  | 1,344 |  |  |  | 8,603 |  |  |  | 209 |
Consolidated net income (loss) |  | $ | 668 |  |  | $ | (2,014 | ) |  | $ | 13,826 |  |  | $ | 8,616 |
_________________________ (1) Includes loss (gain) on foreign currency transaction, loss on available-for-sale securities and income tax expense.
Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties | The Company’s net revenue as shown on the condensed consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net revenue: |  |  |  |  |  |  |  |  |  |  |  |
Product revenue (1) |  | $ | 44,678 |  |  | $ | 46,758 |  |  | $ | 92,469 |  |  | $ | 89,986 |
Services (2) |  |  | 621 |  |  |  | 36 |  |  |  | 1,179 |  |  |  | 420 |
Royalties (3) |  |  | 31,228 |  |  |  | 25,592 |  |  |  | 61,233 |  |  |  | 48,243 |
Total net revenue |  | $ | 76,527 |  |  | $ | 72,386 |  |  | $ | 154,881 |  |  | $ | 138,649 |
_________________________ (1) Amounts represent the revenue from Afrezza and V-Go sales to wholesalers and specialty pharmacies and Tyvaso DPI to UT. (2) Amounts represent revenue generated from the Company's collaboration arrangements, including Next-Gen R&D Services (as defined in Note 9) for UT as well as arrangements with other collaboration partners. See Note 9 – Collaborations, Licensing and Other Arrangements. (3) Amounts represent royalties on UT’s net revenue from Tyvaso DPI sales.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration